Hongkong XinRunde Chemical Co., Ltd

 

Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsAnti Hair Loss Powder

API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5

API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5

API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5
API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5

Large Image :  API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5 Get Best Price

Product Details:
Place of Origin: China
Brand Name: XRD
Certification: GMP
Model Number: 872365-14-5
Payment & Shipping Terms:
Minimum Order Quantity: negotiable
Price: Inquiry for Negotiable
Packaging Details: 1-2 kg / aluminum foil bag, 25kg/ drum, as required
Delivery Time: 1-2days after payment received
Payment Terms: T/T bank, Western Union, Bitcoin, Etc
Supply Ability: 100KG/ Month
Detailed Product Description
CAS: 872365-14-5 Product Name: Fevipiprant
Type: Anti-hair Loss Powder Appearance: White Powder
Usage: Anti-hair Loss Powder Alias: Fevipiprant
Assay: 99% Key Words: Fevipiprant
High Light:

anti estrogen steroids

,

hair growing powder

Anti-hair Loss Powder API Fevipiprant(NVP-QAW039) Fevipiprant CAS 872365-14-5

 

 

Quick Details

 

Name Formestane
CAS No. 566-48-3
EINECS N/A
MF C19H26O3
MW 302.41
MP 199-202°C
Storage temp. 2-8°C
Purity 99% min
Usage An antitumor drug. An aromatase inhibitor
Appearance Needles

Formestane also is known as lentaron,is an anti-cancer drug, it is primarily used for the treatment of postmenopausal women with advanced breast cancer, it is also effective in prostate cancer

 

 

Introduction:

 

1) Product Name:Supply Anti-hair Fevipiprant powder CAS 872365-14-5

2) Purity: ≥99%
3) Appearance: White fine powder
4) Introduction:

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).[1][2][3
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]

 

Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

 

 

API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5 0

 

 

API Fevipiprant NVP - QAW039 Anti Estrogen Steroids CAS 872365-14-5 1

 

 

 

 

Anti-hair Loss Powder API Fevipiprant(NVP-QAW039) Fevipiprant CAS 872365-14-5

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: bruce

Tel: +8618874586545

Send your inquiry directly to us